Company · CIK 0001034842 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RIGEL PHARMACEUTICALS INC · RIGL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 FMForm 4 → | Sep 3, 7:02 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 5,528 | $26.05 | $144,009 | 82,962 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 7:01 pm EDT | David A SantosEVP, Chief Commercial Officer | 874 | $47.50 | $41,515 | 61,622 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:59 pm EDT | Raul R RodriguezCEO, President, Director | 2,424 | $47.50 | $115,140 | 273,362 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 6:59 pm EDT | Raymond J. FureyEVP, GC, CCO & Corp Sec | 877 | $47.50 | $41,658 | 50,559 | — | |
| Jul 8, 2026 AForm 4 → | Jul 10, 9:53 pm EDT | Alison L. HannahEVP, Chief Medical Officer | 24,400 | — | — | 35,025 | — | |
| Jun 22, 2026 SForm 4 → | Jun 24, 4:04 pm EDT | Kamil Ali-JacksonDirector | 2,500 | $35.00 | $87,500 | 10,125 | −19.8% | 10b5-1 |
| Jun 1, 2026 FMForm 4 → | Jun 3, 6:03 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 4,309 | $18.07 | $77,849 | 78,790 | — | |
| Jun 1, 2026 FForm 4 → | Jun 3, 6:02 pm EDT | David A SantosEVP, Chief Commercial Officer | 874 | $29.86 | $26,098 | 61,996 | — | |
| Jun 1, 2026 FForm 4 → | Jun 3, 6:02 pm EDT | Lisa RojkjaerEVP, Chief Medical Officer | 850 | $29.86 | $25,381 | 34,003 | — | |
| Jun 1, 2026 FForm 4 → | Jun 3, 6:01 pm EDT | Raul R RodriguezCEO, President, Director | 2,424 | $29.86 | $72,381 | 279,593 | — | |
| Jun 1, 2026 FForm 4 → | Jun 3, 6:01 pm EDT | Raymond J. FureyEVP, GC, CCO & Corp Sec | 877 | $29.86 | $26,187 | 50,936 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 MForm 4 → | Sep 3, 7:02 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 4,600 | — | — | 15,867 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:12 pm EDT | Raymond J. FureyEVP, GC, CCO & Corp Sec | 7,394 | — | — | 7,394 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:11 pm EDT | Lisa RojkjaerEVP, Chief Medical Officer | 16,769 | — | — | 7,394 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:11 pm EDT | Raul R RodriguezCEO, President, Director | 31,700 | — | — | 31,700 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:11 pm EDT | David A SantosEVP, Chief Commercial Officer | 7,394 | — | — | 7,394 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:11 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 7,394 | — | — | 7,394 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 6:03 pm EDT | Dean L SchornoEVP & Chief Financial Officer | 3,381 | — | — | 13,518 | — |